Efficacy and Safety for Medicurtain® in Prevention of Adhesion After Endoscopic Sinus Surgery (Pivotal Study)
- Conditions
- Tissue Adhesion, Surgery-InducedSinusitis
- First Posted Date
- 2021-09-20
- Last Posted Date
- 2021-09-20
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 77
- Registration Number
- NCT05049434
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SP-8008
- Conditions
- Acute Coronary SyndromeStroke
- Interventions
- Drug: SP-8008 Prototype Capsule ADrug: SP-8008 Prototype Capsule BDrug: Placebo
- First Posted Date
- 2021-02-25
- Last Posted Date
- 2021-02-25
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT04770194
- Locations
- 🇬🇧
Quotient Sciences, Nottingham, Nottinghamshire, United Kingdom
The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients
- Conditions
- Covid19
- Interventions
- Drug: Artecom® (pyronaridine-artesunate)Drug: Placebo
- First Posted Date
- 2021-01-08
- Last Posted Date
- 2021-09-30
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 402
- Registration Number
- NCT04701606
- Locations
- 🇵🇭
De La Salle University Medical Center, Dasmariñas, Gov, D. Mangubat St, 4114 Cavite, Philippines
🇵🇭The Medical City, Pasig City, Ortigas Avenue, Barangay Ugong, Metro Manila, Philippines
🇵🇭Lung Center of the Philippines, Quezon City, Quezon Avenue, Quezon City, 1100 Philippines, Philippines
Spine Surgery for Adhesions in Patients Evaluated for Efficacy and Safety of MedicurtainⓇ (Pivotal Study)
- Conditions
- Lumbosacral Intervertebral Disc DisordersTissue Adhesion, Surgery-InducedIntervertebral Disc DisorderThoracic Intervertebral Disc DisordersThoracolumbar Intervertebral Disc Disorders
- First Posted Date
- 2020-12-29
- Last Posted Date
- 2021-09-29
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 87
- Registration Number
- NCT04688281
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gangnam-gu, Ilwon-dong 50, Korea, Republic of
The Efficacy and Safety of Medicurtain® in Patients With Total Laparoscopic Hysterectomy (Pivotal Study)
- Conditions
- Tissue Adhesion, Surgery-InducedLaparoscopyLeiomyoma of the Uterine Body
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2021-09-29
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 107
- Registration Number
- NCT04672421
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Seoul Asan Medical Center Gil, Songpa-gu, Korea, Republic of
The Efficacy and Safety of Medicurtain® in Patients With Hysteroscopy (Pivotal Study)
- Conditions
- Intrauterine SynechiaeTissue Adhesion, Surgery-Induced
- First Posted Date
- 2020-11-20
- Last Posted Date
- 2021-09-29
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 223
- Registration Number
- NCT04638855
- Locations
- 🇰🇷
Gangnam Severance Hospital, Seoul, Korea, Republic of
COVID-19 Treatment in South Africa
- Conditions
- COVID-19
- Interventions
- Other: Standard of care (Paracetamol)Drug: Artesunate-amodiaquineDrug: Pyronaridine-artesunateDrug: Sofosbuvir/daclatasvir
- First Posted Date
- 2020-08-31
- Last Posted Date
- 2021-09-20
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 192
- Registration Number
- NCT04532931
- Locations
- 🇿🇦
Ezintsha, Wits Reproductive Health & HIV Institute University of the Witwatersrand, Johannesburg, South Africa
Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2023-03-08
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 178
- Registration Number
- NCT04479449
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients
- Conditions
- COVID-19
- Interventions
- Drug: Pyronaridine-ArtesunateDrug: Placebo
- First Posted Date
- 2020-07-17
- Last Posted Date
- 2021-06-01
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 113
- Registration Number
- NCT04475107
- Locations
- 🇰🇷
Korea University Ansan Hospital, Ansan, Korea, Republic of
🇰🇷Chungnam national University Hospital, Daejeon, Korea, Republic of
🇰🇷Inha University Hospital, Incheon, Korea, Republic of
Pyramax in Asymptomatic Carriers of P. Falciparum Monoinfections
- Conditions
- Malaria,Falciparum
- First Posted Date
- 2019-01-24
- Last Posted Date
- 2019-09-30
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 300
- Registration Number
- NCT03814616
- Locations
- 🇬🇲
MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine,, Fajara,, Banjul,, Gambia
🇿🇲Tropical Diseases Research Centre, Ndola, Zambia